Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Integration of Immunologic Phenotyping with Computational Approaches to Predict Clinical Trajectory in Septic Patients

Award Number: R35GM150695
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/01/2023
PERIOD OF PERFORMANCE END DATE: 05/31/2028

Group Awards By:

View Award Description

Integration of Immunologic Phenotyping with Computational Approaches to Predict Clinical Trajectory in Septic Patients - Project Summary/Abstract Sepsis is a global epidemic with a high patient morbidity and mortality, and it accounts for staggering healthcare costs both within the US and worldwide. Clinicians caring for septic patients are unable to distinguish between septic patients who will rapidly recover and those patients who will develop a prolonged disease course marked by immune dysfunction, infectious complications, chronic critical illness (CCI) and death. This affects their ability to weigh the clinical risks versus benefits of immune-adjuvant therapy, in cases where sepsis is characterized by marked immune paralysis. The long-term research goals are (1) to develop novel, rapid and personalized tools with which to predict the prognostic trajectory of septic patients based on underlying immune phenotype, and (2) to integrate this information into the clinical care of septic patients. The subject of this proposal encompasses the first of these two goals, with objectives aligning with the NIGMS Sepsis Research priorities (NOT-GM-19-054). Specifically, we will continue recruitment into an ongoing, prospective, observational, clinical research trial enrolling patients suffering from acute sepsis at a tertiary care, academic medical center. We will utilize a combination of immune-based assays and computational approaches to (i) Validate the prognostic value of rapid, microfluidic cytokine analysis, following ex vivo stimulation of whole blood. Hypothesis: functional immune phenotyping can identify septic patients with subclinical immune paralysis who are prone to secondary infections. Approach: Quantitative analyses comparing cytokine responses to immune adjuvants before and after ex vivo stimulation of whole blood. Microfluidic cytokine analysis provides rapid and precise measurements and that are compatible with a clinical, point of care test. (ii) Compare the CCI syndrome following medical and surgical sepsis. Hypothesis: Iatrogenic tissue damage and inflammation caused by surgery alters the immune response and pathophysiology of CCI in surgical patients, as compared with medical patients. We will use a combination of transcriptomic and metabolomic data to confirm current theories of CCI pathophysiology in surgical patients, and then explore how it differs in patients having medical sepsis. (iii) Develop high fidelity, in vitro models of human myeloid-derived suppressor cells (MDSCs) with which to perform preclinical testing of potential therapies for sepsis-induced CCI. Hypothesis: human MDSCs (immature myeloid cells that expand during chronic infection and suppress immune responses) can be generated through differentiation from peripheral blood mononuclear cells isolated from whole blood. These cells can be used as a novel preclinical model with which to test potential therapies for CCI that are extrapolated from the treatment of cancer. The PI of this grant application is a clinician- scientist and the current recipient of a K08 award from the NIGMS which studies sepsis. He is ready to progress to scientific independence via the R-35 grant mechanism for early-stage investigators.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $418,500 )
2026	2026	PENNSYLVANIA STATE UNIVERSITY	500 UNIVERSITY DRIVE	HERSHEY	PA	17033	DAUPHIN	USA	Biomedical Research and Research Training	000	4	5/22/2026	NON-COMPETING CONTINUATION	$418,500
														Subtotal = $418,500

Issue Date FY: 2025 ( Subtotal = $418,500 )
2025	2025	PENNSYLVANIA STATE UNIVERSITY	500 UNIVERSITY DRIVE	HERSHEY	PA	17033	DAUPHIN	USA	Biomedical Research and Research Training	000	3	5/13/2025	NON-COMPETING CONTINUATION	$418,500
														Subtotal = $418,500

Issue Date FY: 2024 ( Subtotal = $433,338 )
2024	2024	PENNSYLVANIA STATE UNIVERSITY	500 UNIVERSITY DRIVE	HERSHEY	PA	17033	DAUPHIN	USA	Biomedical Research and Research Training	000	2	5/16/2024	NON-COMPETING CONTINUATION	$418,500
2024	2024	PENNSYLVANIA STATE UNIVERSITY	500 UNIVERSITY DRIVE	HERSHEY	PA	17033	DAUPHIN	USA	Biomedical Research and Research Training	001	2	9/4/2024	SUPPLEMENT FOR EXPANSION	$14,838
														Subtotal = $433,338

Issue Date FY: 2023 ( Subtotal = $418,500 )
2023	2023	PENNSYLVANIA STATE UNIVERSITY	500 UNIVERSITY DRIVE	HERSHEY	PA	17033	DAUPHIN	USA	Biomedical Research and Research Training	000	1	7/24/2023	NEW	$418,500
														Subtotal = $418,500

Grand Total All Awards = $1,688,838

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Integration of Immunologic Phenotyping with Computational Approaches to Predict Clinical Trajectory in Septic Patients

Award Number: R35GM150695

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/01/2023

PERIOD OF PERFORMANCE END DATE: 05/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer